aTYR PHARMA INC (ATYR)
aTYR PHARMA INC (ATYR) has reported earnings 19 times since May 13, 2021. The stock moves an average of ±5.05% the day after reporting, closing higher 73.7% of the time. Its largest post-earnings gain was +22.84% (Mar 14, 2024) and its largest decline was -10.14% (May 15, 2026). The next earnings report is predicted for 2026-11-06 (approximate).
Earnings reactions
How ATYR moved on each past earnings report.
Earnings Impact
Total Earnings
19
Avg Abs. Movement
±5.05%
Positive %
73.7%
Negative %
26.3%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 07, 2026 | ☽ POST | +1.75% | open_in_new |
| May 15, 2026 | ☀ PRE | -10.14% | open_in_new |
| Mar 05, 2026 | ☽ POST | -8.65% | open_in_new |
| Nov 06, 2025 | ☽ POST | +6.1% | open_in_new |
Earnings Count
19
Total earnings in dataset
Avg Abs. Movement
±5.05%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| PRE 14A | 20260831 | open_in_new SEC.gov |
| 10-Q | 20260807 | open_in_new SEC.gov |
| 8-K | 20260807 | open_in_new SEC.gov |
| S-8 | 20260807 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260806 | open_in_new SEC.gov |
| 8-K | 20260731 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260727 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260708 | open_in_new SEC.gov |
| 8-K | 20260608 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260605 | open_in_new SEC.gov |
Frequently asked about ATYR earnings
When does aTYR PHARMA INC report earnings next? expand_more
aTYR PHARMA INC (ATYR)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does ATYR stock move after earnings? expand_more
Over 19 reports, ATYR has moved an average of ±5.05% the session after earnings, closing higher 73.7% of the time.
What was ATYR's biggest post-earnings move? expand_more
ATYR's largest post-earnings gain on record was +22.84% on Mar 14, 2024, and its largest decline was -10.14% on May 15, 2026.
Where can I find aTYR PHARMA INC's SEC filings? expand_more
All of aTYR PHARMA INC's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right